The FDA has labeled a recall of Inspire Medical Systems, Inc.'s INSP nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind.
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.